NIH Reporter #1K08DK140618-01A1

Research Services for RUNX1 in Biliary Fibrosis at Virginia Commonwealth University

This opportunity from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) seeks research services for a project at Virginia Commonwealth University focused on biliary fibrosis. - Government Buyer: - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health - Research to be conducted at Virginia Commonwealth University, Richmond, VA - Products/Services Requested: - Research services involving transcriptomics and lipidomics analyses - Study of the transcription factor RUNX1 in TGFβ-activated cholangiocyte signaling and immune system interactions - Development of therapeutic strategies for biliary fibrosis - OEMs and Vendors: - No specific OEMs or commercial vendors are named in the solicitation - Unique/Notable Requirements: - Expertise in advanced molecular biology techniques - Ability to conduct comprehensive analyses of signaling pathways and immune interactions - Focus on developing new therapeutic approaches for biliary fibrosis - Estimated Contract Value: - $176,094 - No set-aside or license restrictions specified

Description

This is a research grant opportunity focused on the role of RUNX1 in biliary fibrosis, specifically its involvement in TGF signaling pathways and interactions with the immune system. The project aims to develop therapeutic strategies and involves multiple analyses including transcriptomics and lipidomics. The research is conducted by Virginia Commonwealth University under the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The solicitation is open and active with a response deadline of November 4, 2023.

View original listing